top of page
BBG_Partner-Siegel_RGB_RZ.png

PPE-Products

Our articles are high-quality, certified products that guarantee protection and safety.

Together for safety, because your health is important to us.

Antigentests - professional

Flowflex SARS-Cov-2- rapid antigentest

A rapid test for the qualitative detection of SARS-CoV2 nucleocapsid antigens in nasal and nasopharyngeal swab specimens.

Materials provided:

  • 25 test cassettes: each test cassette packed in foil pouches with desiccant.

  • 25 Exraction Buffer Tubes

  • 25 Sterilised swabs: Disposable swabs for specimen collection.

  • Postitive/negative control - 1 stick each

  • 1 workstation

  • 1 package insert

 

The test may only be performed by healthcare professionals or specially trained professionals

 

Certification:

DIN EN ISO 13485:2016 - In-vitro-Diagnostic

RL 98/79/EG Annex 3

Flowflex SARS-Cov-2- rapid antigen test

A rapid test for the qualitative detection of SARS-CoV2 nucleocapsid antigens in nasal and nasopharyngeal swab specimens.

Materials provided:

  • 20 test cassettes: each test cassette packed in foil pouches with desiccant.

  • 20 Exraction Buffer Tubes

  • 20 Sterilised swabs: Disposable swabs for nasal sampling

  • 20 Sterilised swabs: disposable swabs for nasopharyngeal sampling

  • 1 package insert

 

The test may only be performed by healthcare professionals or specially trained professionals!

 

Certification:

DIN EN ISO 13485:2016 - In-vitro-Diagnostic

RL 98/79/EG Annex 3

Antigentests - self testing

Flowflex SARS-Cov-2 Rapid Antigen Test (Self-Test)

A rapid test for the qualitative detection of SARS-CoV2 nucleocapsid antigens in anterior nasal swab specimens.

Package sizes: Single test, 5 tests, 25 tests

Materials provided:

  • Test cassettes: each test cassette packed in foil pouch with desiccant.

  • Extraction buffer tubes

  • Sterilised swabs: Disposable swabs for nasal sampling

  • Waste bags

  • 1 package insert

 

Certification

DIN EN ISO 13485:2016 - In-vitro-Diagnostics

RL 98/79/EG Annex 3

bottom of page